-
Following critical feedback and possible IRS conflicts, an HHS FAQ walks back recent pharmacy rules.September 27
Senior vice president, benefits consultingCBIZ -
While the finalized regulation makes health reimbursement arrangements more accessible, employers should still continue to boost healthcare literacy, experts say.June 14
-
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.February 7
-
The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.February 5
-
The Trump administration’s new prescription drug proposal is vital to correct an increasingly dysfunctional market for employer plan sponsors.February 4
CEONational Alliance of Healthcare Purchaser Coalitions
-
HHS' Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.June 13
-
Ex-president of Eli Lilly's U.S. arm, Alex Azar, was confirmed to head the Department of Health and Human Services, setting a permanent replacement for Tom Price.January 24
-
Nominee Alex Azar was an executive at drugmaker Eli Lilly & Co. until January, a role that Democrats say raises concerns about whether he will take on high drug pricesNovember 29
-
President Donald Trump named former Eli Lilly & Co. executive Alex Azar to lead the Department of Health and Human Services.November 13
-
Eric Hargan has held various positions in the department, including deputy secretary, under President George W. Bush.October 11
